powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1336438258
David Wise
M.D., PH.D.
PRACTICE
NEW YORK UNIVERSITY
See all providers at this practice →
Medical Oncology
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
PRESCRIBING · PART D · 2024
Total Rx claims
1,087
Beneficiaries
—
Total drug cost
$5.2M
Distinct drugs
15
Brand share
45.6%
Top prescribed drugs
Prednisone
210 claims
Abiraterone Acetate
197 claims
Darolutamide
151 claims
Relugolix
145 claims
Enzalutamide
117 claims
QUALITY · MIPS · 2024
Final MIPS score
90.8
Quality
91.8
Cost
75.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.66%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
3
By payment type
Consulting Fee
$3K
Food and Beverage
$150
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
494
Unique beneficiaries
—
Total services
894
Distinct HCPCS
7
Medicare payment
$80K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — top quintile (cohort median 458).